689 related articles for article (PubMed ID: 17004982)
21. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
Bhavi SB; Jaju PB
BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
Geisser P; Rumyantsev V
Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
Bailie GR
Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
[TBL] [Abstract][Full Text] [Related]
24. Body iron and individual iron prophylaxis in pregnancy--should the iron dose be adjusted according to serum ferritin?
Milman N; Byg KE; Bergholt T; Eriksen L; Hvas AM
Ann Hematol; 2006 Sep; 85(9):567-73. PubMed ID: 16733739
[TBL] [Abstract][Full Text] [Related]
25. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
McMahon LP; Kent AB; Kerr PG; Healy H; Irish AB; Cooper B; Kark A; Roger SD
Nephrol Dial Transplant; 2010 Mar; 25(3):920-6. PubMed ID: 19906658
[TBL] [Abstract][Full Text] [Related]
26. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
Kochhar PK; Kaundal A; Ghosh P
J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study.
Nappi C; Tommaselli GA; Morra I; Massaro M; Formisano C; Di Carlo C
Acta Obstet Gynecol Scand; 2009; 88(9):1031-5. PubMed ID: 19639462
[TBL] [Abstract][Full Text] [Related]
28. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
29. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
30. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
Lindgren S; Wikman O; Befrits R; Blom H; Eriksson A; Grännö C; Ung KA; Hjortswang H; Lindgren A; Unge P
Scand J Gastroenterol; 2009; 44(7):838-45. PubMed ID: 19330567
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
Geisser P; Banké-Bochita J
Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
[TBL] [Abstract][Full Text] [Related]
32. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
[TBL] [Abstract][Full Text] [Related]
35. Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women.
Milman N; Bergholt T; Eriksen L; Byg KE; Graudal N; Pedersen P; Hertz J
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):238-47. PubMed ID: 15715531
[TBL] [Abstract][Full Text] [Related]
36. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex.
Breymann C; von Seefried B; Stahel M; Geisser P; Canclini C
J Perinat Med; 2007; 35(2):115-8. PubMed ID: 17302514
[TBL] [Abstract][Full Text] [Related]
37. Intravenous versus oral iron therapy for postpartum anaemia.
Jatoth P; Coundjidapadam CS
BJOG; 2007 May; 114(5):655; author reply 655-6. PubMed ID: 17439582
[No Abstract] [Full Text] [Related]
38. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
Pfenniger A; Schuller C; Christoph P; Surbek D
J Perinat Med; 2012 Apr; 40(4):397-402. PubMed ID: 22752771
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Pinsk V; Levy J; Moser A; Yerushalmi B; Kapelushnik J
Isr Med Assoc J; 2008 May; 10(5):335-8. PubMed ID: 18605353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
